Shares of space names are sliding Friday morning as a sharp one-month reversal deepens across the sector.
Some Amazon cloud customers woke up on Friday to a surprise bill estimate that said they owed billions of dollars for cloud services they had never used.
SpaceX (NASDAQ:SPCX | SPCX Price Prediction) investors are watching retirement savings crater.
IMAX Corp (NYSE:IMAX) is positioned for a stronger second half of 2026 despite expectations for modest second quarter growth, according to Wedbush, which reiterated its ‘Outperform' rating and $46 price target ahead of the company's earnings report. Shares of IMAX traded hands at $38 on Friday morning, up about 5% so far this year.
Husqvarna AB (publ) (HSQVY) Q2 2026 Earnings Call Transcript
ASSA ABLOY AB (publ) (ASAZY) Q2 2026 Earnings Call Transcript
South Plains Financial, Inc. (SPFI) Q2 2026 Earnings Call Transcript
Truist's Q2 earnings beat estimates as higher NII and fee income, loan growth and lower provisions offset rising expenses and margin pressure.
Chevron's premium assets, strong balance sheet and steadier earnings outlook give it a slight edge over TotalEnergies for long-term investors.
GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech.
ManpowerGroup beats Q2 earnings and revenue estimates as broad regional growth, cost discipline and stronger demand support results and its Q3 outlook.
Esquire Financial (ESQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Alphabet shares currently trade at $354.46 while Wall Street's consensus analyst price target sits at $431.72, a gap of roughly 21.8% between current price and fair value.
Crypto ETF demand split sharply on Thursday, July 16, as bitcoin products drew $79.15 million while ether funds lost $28.04 million. XRP and Solana ETFs also attracted fresh capital, while T. Rowe Price launched a multi-token fund with an unusually large HYPE allocation.
BWX Technologies expands manufacturing investments to strengthen production capacity across defense, commercial nuclear and advanced reactor markets.
GSK drops camlipixant's refractory chronic cough program after mixed phase III results, but the drug remains in a phase IIb study for irritable bowel syndrome.
Texas Instruments is poised for a Q2 earnings beat as analog and embedded chip demand rises, led by industrial, data center and automotive strength.
SpaceX (SPCX) stock is tumbling further this morning after the firm's 13th Starship test flight was aborted right before liftoff as several engines failed to start properly. The development adds fuel to the bearish fire that has already assembled a $25 billion wall against billionaire Elon Musk's space infrastructure and artificial intelligence (AI) behemoth.
Morgan Stanley has completed the rollout of Bitcoin, Ethereum, and Solana trading on E*TRADE, charging eligible clients a 0.50% fee on each transaction.
Truecaller AB (publ) (TRUBF) Q2 2026 Earnings Call Transcript
Alleima AB (publ) (SAMHF) Q2 2026 Earnings Call Transcript
USD/JPY USD/JPY closes week at an increasingly important technical juncture after spending the past three weeks consolidating within the July opening range. The pullback from the monthly highs found support at a key confluence zone, preserving the broader uptrend while allowing the pair to work off overextended conditions.
I keep buying Meta Platforms (NASDAQ:META | META Price Prediction), and I am not planning to stop.
JBTH, TSM and JPM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 17, 2026.
Strategy CEO Phong Le has sought to reassure investors that the company's balance sheet remains resilient despite Bitcoin's latest downturn.
Other food and restaurant stocks jumped, too, as investors likely hope that customers will resume their normal food-shopping habits.
Apple is reclaiming the top spot for the first time since April last year.
QuantumScape is rated a buy due to its strong execution on the Eagle Line pilot, signaling near-term commercialization potential. QS's Cobra process now achieves heat treatment speeds 25x faster, supporting scalable battery production and competitive energy densities up to 850 Wh/L. Customer billings are accelerating, with FY2026 annualized projections of $44 million, indicating robust B1 sample acceptance and readiness for automotive commercialization.
Novo Nordisk has made robust gains of 40% at the stock markets since April, supported by the success of oral Wegovy and attractive valuations. The Wegovy pill can see a nice revenue uptick in Q2 2026 going by recent data, and that can continue into the year as it gains approvals from international markets. Importantly, the pill has made gains even when competitor Eli Lilly's Foundayo has seen limited success, which can give Novo Nordisk a much-needed boost.
RF tops Q2 earnings estimates as NII and improving credit quality offset expense growth, but revenues fall short of expectations.